Eicosadienoic Acid.
Your body builds this omega-6 fat from the linoleic acid in seed oils and nuts, then parks it in cell membranes. On a fatty acid panel it reads as how busy that pathway is.
- Category
- Fatty acid
What Eicosadienoic Acid is, and what it does.
- Does it work
- It isn't sold to take. It matters to people reading a fatty acid panel and to anyone tracking how their omega-6 and omega-3 intakes are shifting.
- How much to take
- No intake amount is on record, and no daily target has been set for it, because your body makes it rather than needing it from the plate.
- Time to feel it
- Membrane fatty acid proportions shift over weeks to months as the fats you eat change, and that change reads on a blood panel.
- The first dose
- Day one brings no sensation. What moves first is membrane lipid composition, which a fatty acid panel picks up much later.
- With regular use
- Over weeks of steady eating, its share in red cell membranes tracks your linoleic acid intake and falls as EPA and DHA intake rises.
- How well tolerated
- It's a normal part of human tissue and of everyday food fats, and no separate tolerance data exists. Ask a clinician before a large change in dietary fat.
- How it feels
- There's no subjective experience. It registers as a percentage on a fatty acid panel rather than as anything you sense.
- The overlooked benefit
- Its level is a readout of elongase activity, so a rising share can flag that omega-6 elongation is running ahead of your omega-3 intake.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
- membrane phospholipid compositionNarrative review
- marker of omega-6 elongation activity in blood lipidsNarrative review
- response of the tissue fatty acid profile to dietary fat intakeCohort study
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Eicosadienoic acid, 20:2n-6, is formed when the elongase ELOVL5 adds two carbons to linoleic acid. Dietary linoleic acid supply therefore sets how much of it appears in tissue lipids. In practice most measured 20:2n-6 in humans comes from this elongation rather than from the diet.
Linoleic acid can either be desaturated by delta-6 desaturase toward GLA and then dihomo-gamma-linolenic acid, or elongated directly to 20:2n-6. The two routes draw on the same substrate pool, so a rise in 20:2n-6 often reflects flow through the elongation branch. Supplying GLA directly bypasses the desaturation step that is usually rate limiting.
The n-6 and n-3 families are elongated and desaturated by the same enzymes, and those enzymes prefer the n-3 substrates. Raising EPA and DHA intake therefore shifts the whole n-6 elongation series, including 20:2n-6, downward in membrane phospholipids. This is why fatty acid panels change across the board after fish oil rather than only in the n-3 columns.
Delta-6 and delta-5 desaturases lose activity in zinc deficiency, and the classic marker of that deficiency is an altered ratio between the 20-carbon n-6 fatty acids. When desaturation is impaired the elongation route becomes relatively more prominent. The relevance is to deficiency states, not to routine supplementation.
Desaturase activity in the n-6 series is reduced in vitamin B6 depletion, which changes the balance of 20-carbon products in tissue lipids. As with zinc, this describes what happens when status is inadequate rather than a reason to add more. The measured consequence is a shift in the fatty acid profile, a marker, not an outcome.
Any polyunsaturated fatty acid with two or more double bonds is subject to chain autoxidation in oils and in membranes. Alpha-tocopherol donates a hydrogen atom to break that chain. Oils rich in 20-carbon polyunsaturates carry tocopherols for this reason, whether naturally present or added.
Evening primrose oil is mostly linoleic acid with a GLA fraction, so it feeds both branches of the n-6 pathway, elongation and desaturation. Anyone taking it will shift their 20-carbon n-6 profile including 20:2n-6. Whether that shift matters clinically is not something the fatty acid measurement itself answers.
Arachidonic acid is the major 20-carbon n-6 product and the substrate for the eicosanoid enzymes. 20:2n-6 shares the same carbon number and the same lipid pools but is not a cyclooxygenase or lipoxygenase substrate in the same way. In a fatty acid panel the two move for related but distinct reasons.
Nothing specific on file for Eicosadienoic Acid. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Eicosadienoic Acid actually does.
This is a 20-carbon omega-6 fat with two double bonds.
The body makes it by extending linoleic acid, which is why its level in tissue tends to track how much linoleic acid you eat and how active that extension enzyme is.
It sits in the same omega-6 pathway as a few other fats, competing with them for the same processing enzymes.
It's built into cell membranes and shows up on blood fat panels as a marker of omega-6 pathway activity rather than a nutrient with its own intake target.
Where Eicosadienoic Acid comes from.
This is a fatty acid your body builds from the linoleic acid in ordinary seed oils and nuts. It shows up on blood fatty acid tests, and it moves when your omega-6 and omega-3 intakes change. It is not something sold to take, and there is no established intake target for it.
The same molecule is reached more than one way. Which route a given product used is a manufacturing choice, and the finished compound is the same either way.
Dietary linoleic acid is the biological starting point. Isolated material is made from natural oil fractions or by chemical synthesis.
ELOVL5 elongates 18:2n-6 to 20:2n-6 in the endoplasmic reticulum using malonyl-CoA as the carbon donor.
Isolated 20:2n-6 is separated to high purity from mixed fatty acid pools and stored under inert gas.
Supplied as an analytical or cell culture reagent rather than as a dosage form.
Getting Eicosadienoic Acid from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- Adding eicosadienoic acid to cultured CHO cells extended culture longevity and raised antibody output, a bioprocessing observation rather than a nutritional one.In vitro study. Pei X et al., 2026 (AMB Express). PMID 41936736 ↗
- Twelve weeks of EPA plus DHA supplementation shifted the whole erythrocyte fatty acid profile, with the n-6 series including eicosadienoic acid moving alongside the n-3 fatty acids.Open-label trial. Tomczyk M et al., 2026 (Prostaglandins, Leukotrienes and Essential Fatty Acids). PMID 41349157 ↗
- A dietary herbal formula changed the fatty acid composition of egg yolk, with shifts across several 20-carbon fatty acids including eicosadienoic acid.Animal study. Li Z et al., 2024 (The Veterinary Quarterly). PMID 38404134 ↗
- Maternal zinc bis-glycinate supplementation altered the milk lipidomic profile, showing that mineral status can shift which fatty acids appear in milk lipids.Animal study. Ruampatana J et al., 2026 (Veterinary and Animal Science). PMID 42181090 ↗
These are the studies our verdict leans on, chosen from the 4 we read for Eicosadienoic Acid. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.